Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)

Antoine Vasseur; Luc Cabel; Olivier Tredan; Marion Chevrier; Coraline Dubot; Véronique Lorgis; William Jacot; Anthony Goncalves; Marc Debled; Christelle Levy; Jean-Marc Ferrero; Christelle Jouannaud; Elisabeth Luporsi; Marie-Ange Mouret-Reynier; Florence Dalenc; Jerome Lemonnier; Alexia Savignoni; Marie-Laure Tanguy; Francois-Clement Bidard; Jean-Yves Pierga